Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment

BACKGROUND: Tamoxifen (TAM) is used in breast cancer treatment, but interindividual variabilities in TAM-metabolizing enzymes exist and have been linked to single nucleotide polymorphisms in the respective encoding genes. The different alleles and genotypes of these genes have been presented for Cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Charoenchokthavee, Wanaporn, Panomvana, Duangchit, Sriuranpong, Virote, Areepium, Nutthada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982506/
https://www.ncbi.nlm.nih.gov/pubmed/27540311
http://dx.doi.org/10.2147/BCTT.S105563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982506/
https://www.ncbi.nlm.nih.gov/pubmed/27540311
http://dx.doi.org/10.2147/BCTT.S105563

Ejemplares similares